137 related articles for article (PubMed ID: 2876796)
1. Alpha-1-adrenergic blockade and lipoprotein metabolism in essential hypertension.
Ferrier C; Beretta-Piccoli C; Weidmann P; Mordasini R
Clin Pharmacol Ther; 1986 Nov; 40(5):525-30. PubMed ID: 2876796
[TBL] [Abstract][Full Text] [Related]
2. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
[TBL] [Abstract][Full Text] [Related]
3. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
Titmarsh S; Monk JP
Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
[TBL] [Abstract][Full Text] [Related]
4. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
5. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
Silke B; Guy S; Humphreys JE
J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
[TBL] [Abstract][Full Text] [Related]
7. Terazosin: a new antihypertensive agent with favorable effects on lipids.
Luther RR
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertension.
Black HR; Chrysant SG; Curry CL; Frishman WH; Grimm RH; Lasseter KC; Okun R; Pool JL; Raizada V; Vlachakis ND
J Clin Pharmacol; 1992 Apr; 32(4):351-9. PubMed ID: 1349028
[TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.
Saunders E
Am Heart J; 1991 Sep; 122(3 Pt 2):936-42. PubMed ID: 1678925
[TBL] [Abstract][Full Text] [Related]
10. Alpha 1-adrenergic blockade and cardiovascular pressor responses in essential hypertension.
Beretta-Piccoli C; Ferrier C; Weidmann P
Hypertension; 1986 May; 8(5):407-14. PubMed ID: 2870984
[TBL] [Abstract][Full Text] [Related]
11. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
Bur A; Woisetschläger C; Herkner H; Derhaschnig U; Quehenberger P; Hirschl MM
Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
[TBL] [Abstract][Full Text] [Related]
12. Postsynaptic alpha 1-blockade with terazosin does not modify insulin sensitivity in nonobese normotensive subjects.
Ferrari P; Rosman J; Neuner N; Shaw S; Riesen W; Weidmann P
J Cardiovasc Pharmacol; 1991 Jul; 18(1):106-10. PubMed ID: 1719277
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of short-term selective alpha 1-adrenergic blockade with terazosin in patients with essential hypertension.
Beretta-Piccoli C; Ferrier C; Weidmann P
J Hypertens Suppl; 1985 Dec; 3(3):S231-4. PubMed ID: 2908818
[TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism.
Ferrara LA; Marotta T; Rubba P; De Simone B; Leccia G; Soro S; Mancini M
Am J Med; 1986 Feb; 80(2A):104-8. PubMed ID: 2868656
[TBL] [Abstract][Full Text] [Related]
15. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
Pool JL
Am Heart J; 1991 Sep; 122(3 Pt 2):926-31. PubMed ID: 1678924
[TBL] [Abstract][Full Text] [Related]
16. Terazosin: a new alpha adrenoceptor blocking drug.
Achari R; Laddu A
J Clin Pharmacol; 1992 Jun; 32(6):520-3. PubMed ID: 1353083
[TBL] [Abstract][Full Text] [Related]
17. Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial.
Goto Y
Am J Med; 1984 Feb; 76(2A):72-8. PubMed ID: 6142645
[TBL] [Abstract][Full Text] [Related]
18. Experience with terazosin administered in combination with other antihypertensive agents.
Chrysant SG
Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and endocrinological effects of a new selective alpha 1-blocking agent, terazosin, in patients with essential hypertension. Results of long-term treatment.
Tomoda F; Takata M; Yoshida K; Yasumoto K; Mikawa M; Sasayama S
Am J Hypertens; 1989 Nov; 2(11 Pt 1):834-9. PubMed ID: 2574044
[TBL] [Abstract][Full Text] [Related]
20. [Pressure and metabolic effects of terazosin in essential hypertension].
Valle R; Semplicini A; Serena L; Gebbin A; Fontebasso A; Gerardi G; De Toni R; Pessina AC
Cardiologia; 1994 Jun; 39(6):421-4. PubMed ID: 7923256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
